CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board - CervoMed (NASDAQ:CRVO)
Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals CervoMed on track to complete enrollment in 1H 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with